Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence and Persistence to Inclisiran Among Early Users in Germany

NCT05870657 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT05870657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence and Persistence to Inclisiran Among Early Users in Germany
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
February 16, 2022
Completion date
May 12, 2022
Enrollment
1,109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high levels of low-density lipoprotein cholesterol